← Back to patent-cliff list
CAS 847233-13-0
4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl methanesulfonate
Codes: TIAG-020
Application context (from source-drug indications)
EpilepsyTiagabine HydrochlorideSeizureTiagabine HydrochlorideAnxiety disorderTiagabine HydrochlorideObstructive sleep apnoea syndromeTiagabine HydrochlorideCocaine addictionTiagabine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tiagabine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-bromo-3-methylthiophene→dihydrofuran-2(3H)-one→1,1-bis(3-methylthiophen-2-yl)butane-1,4-diol→4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl methanesulfonate→methyl 1,2,5,6-tetrahydropyridine-3-carboxylate→methyl 1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)-1,2,5,6-tetrahydropyridine-3-carboxylate→1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)-1,2,5,6-tetrahydropyridine-3-carboxylic acid→TIAG-024
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.